G01N 2333/5753
Calcitonin gene related peptide
G01N2333/5753 (Calcitonin gene related peptide) appears on 14 US grants and 30 published applications in this corpus.
Search patents in G01N- Granted patents
- 14
- Published applications
- 30
- Assignees
- 21
- Inventors
- 53
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 4 |
| 2018 | 1 | 1 |
| 2019 | 1 | 4 |
| 2020 | 3 | 3 |
| 2021 | 1 | 1 |
| 2022 | 2 | 3 |
| 2023 | 1 | 3 |
| 2024 | 3 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of detecting septic arthritis, transient synovitis and osteomyelitis2 Sep 2025US 12,405,276 B2Washington University
- Regulation of glucose metabolism using anti-CGRP antibodies22 Oct 2024US 12,122,821 B2H. Lundbeck A.S.
- Early diagnosis of infections6 Aug 2024US 12,055,545 B2MeMed Diagnostics Ltd.
- Protein signatures for distinguishing between bacterial and viral infections23 Jul 2024US 12,044,681 B2MeMed Diagnostics Ltd.
- Pencil-like optical fiber sensor probe, portable immunosensor and use thereof4 Apr 2023US 11,619,627 B2Changchun JingKeOuDe Science and Education Instrument Co., Ltd.
- Synthetic peptide for use in an immunomolecular assay9 Jul 2026US 2026/0193298 A1Biomerieux
- Anti-cgrp antibody and use7 May 2026US 2026/0125454 A1Shanghai Junshi Biosciences Co., Ltd.
- Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions16 Apr 2026US 2026/0102478 A1Longhorn Vaccines and Diagnostics, LLC
- Protein signatures for distinguishing between bacterial and viral infections19 Dec 2024US 2024/0418716 A1MeMed Diagnostics Ltd.
- Early diagnosis of infections7 Nov 2024US 2024/0369552 A1MeMed Diagnostics Ltd.
Most cited
By later US patents
- Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof17US 10,859,574 B2MeMed Diagnostics Ltd. · 2020
- Diagnosis and treatment of wound infection with procalcitonin as diagnostic marker4US 10,739,352 B2Convatec Technologies Inc. · 2020
- Use of CGRP antagonist compounds for treatment of psoriasis4US 9,585,940 B2Birkir Sveinsson · 2017
- Use of CGRP antagonist compounds for treatment of psoriasis3US 10,668,132 B2Nepsone Ehf · 2020
- Immunoassay for the detection of procalcitonin1US 10,048,280 B2B.R.A.H.M.S GmbH · 2018